NEW YORK (GenomeWeb News) – Genomic Health today reported double-digit growth in fourth-quarter and full-year 2008 revenues, accompanied by a slimmer net loss.

The company posted a 61 percent increase in revenues for the quarter ended Dec. 31, 2008, to $30.9 million from $19.3 million in the fourth quarter of 2007. Product revenue from the company's Oncotype DX breast cancer assay contributed $30.9 million to fourth-quarter revenues, an increase of 60 percent over $19.3 million in product revenue in the fourth quarter of 2007.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Sponsored by

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Sponsored by
Horizon Discovery

In this webinar, Kevin Balbi, head of bioinformatics at Sarah Cannon Molecular Diagnostics, will discuss the validation of targeted sequencing panels on the Ion Torrent platform using Horizon Discovery’s Tru-Q controls.